0001654954-17-005235.txt : 20170531 0001654954-17-005235.hdr.sgml : 20170531 20170531172857 ACCESSION NUMBER: 0001654954-17-005235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170530 FILED AS OF DATE: 20170531 DATE AS OF CHANGE: 20170531 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Latkin Jed CENTRAL INDEX KEY: 0001554593 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 17882448 MAIL ADDRESS: STREET 1: 152 W. 57TH STREET STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 section16.xml FORM 4 LATKIN X0306 4 2017-05-30 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001554593 Latkin Jed 4995 BRADENTON AVE SUITE 240 DUBLIN OH 43017 false true false COO and CFO Common Stock, $.001 par value 2017-05-30 4 P false 7600 .4364 A 50159 D /s/ Jed A. Latkin 2017-05-31